BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34918112)

  • 1. High Prevalence of Early Endocrine Disorders After Childhood Brain Tumors in a Large Cohort.
    González Briceño LG; Kariyawasam D; Samara-Boustani D; Giani E; Beltrand J; Bolle S; Fresneau B; Puget S; Sainte-Rose C; Alapetite C; Pinto G; Piketty ML; Brabant S; Abbou S; Aerts I; Beccaria K; Bourgeois M; Roujeau T; Blauwblomme T; Di Rocco F; Thalassinos C; Pauwels C; Rigaud C; James S; Busiah K; Simon A; Bourdeaut F; Lemelle L; Guerrini-Rousseau L; Orbach D; Touraine P; Doz F; Dufour C; Grill J; Polak M
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2156-e2166. PubMed ID: 34918112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Puberty and Hypothalamic-Pituitary-Gonadal Axis Function After Childhood Brain Tumor Treatment.
    Rosimont M; Kariyawasam D; Samara-Boustani D; Giani E; Beltrand J; Bolle S; Fresneau B; Puget S; Sainte-Rose C; Alapetite C; Pinto G; Touraine P; Piketty ML; Brabant S; Abbou S; Aerts I; Beccaria K; Bourgeois M; Roujeau T; Blauwblomme T; Rocco FD; Thalassinos C; Rigaud C; James S; Busiah K; Simon A; Bourdeaut F; Lemelle L; Guerrini-Rousseau L; Orbach D; Doz F; Dufour C; Grill J; Polak M; Briceño LG
    J Clin Endocrinol Metab; 2023 Aug; 108(9):e823-e831. PubMed ID: 36810692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone deficiency and other endocrinopathies after childhood brain tumors: results from a close follow-up in a cohort of 242 patients.
    Maciel J; Dias D; Cavaco D; Donato S; Pereira MC; Simões-Pereira J
    J Endocrinol Invest; 2021 Nov; 44(11):2367-2374. PubMed ID: 33683662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter Study.
    Clement SC; Schouten-van Meeteren AY; Boot AM; Claahsen-van der Grinten HL; Granzen B; Sen Han K; Janssens GO; Michiels EM; van Trotsenburg AS; Vandertop WP; van Vuurden DG; Kremer LC; Caron HN; van Santen HM
    J Clin Oncol; 2016 Dec; 34(36):4362-4370. PubMed ID: 27998218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine sequelae beyond 10 years in survivors of medulloblastoma.
    Uday S; Murray RD; Picton S; Chumas P; Raju M; Chandwani M; Alvi S
    Clin Endocrinol (Oxf); 2015 Nov; 83(5):663-70. PubMed ID: 25952583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic-pituitary lesions in pediatric patients: endocrine symptoms often precede neuro-ophthalmic presenting symptoms.
    Taylor M; Couto-Silva AC; Adan L; Trivin C; Sainte-Rose C; Zerah M; Valteau-Couanet D; Doz F; Chalumeau M; Brauner R
    J Pediatr; 2012 Nov; 161(5):855-63. PubMed ID: 22727865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Endocrine and Metabolic Comorbidities in a National Cohort of Patients with Craniopharyngioma.
    Jazbinšek S; Kolenc D; Bošnjak R; Faganel Kotnik B; Zadravec Zaletel L; Jenko Bizjan B; Vipotnik Vesnaver T; Battelino T; Janež A; Jensterle M; Kotnik P
    Horm Res Paediatr; 2020; 93(1):46-57. PubMed ID: 32460296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic-pituitary function following childhood brain tumors: Analysis of prospective annual endocrine screening.
    Lawson SA; Horne VE; Golekoh MC; Hornung L; Burns KC; Fouladi M; Rose SR
    Pediatr Blood Cancer; 2019 May; 66(5):e27631. PubMed ID: 30693650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of early hypothalamic-pituitary damage in childhood brain tumor survivors: need for standardized follow-up programs.
    Clement SC; Meeteren AY; Kremer LC; van Trotsenburg AS; Caron HN; van Santen HM
    Pediatr Blood Cancer; 2014 Dec; 61(12):2285-9. PubMed ID: 25131941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Endocrine Disorders in Childhood Brain Tumor Survivors in South Korea.
    Heo J; Lee HS; Hwang JS; Noh OK; Kim L; Park JE
    In Vivo; 2019; 33(6):2287-2291. PubMed ID: 31662569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early development of endocrine and metabolic consequences after treatment of central nervous system tumors in children.
    Ramanauskienė E; Labanauskas L; Verkauskienė R; Sileikienė R
    Medicina (Kaunas); 2014; 50(5):275-80. PubMed ID: 25488163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine manifestations of paediatric intracranial germ cell tumours: from diagnosis to long-term follow-up.
    Partenope C; Pozzobon G; Weber G; Arya VB; Carceller F; Albanese A
    Endocrine; 2022 Sep; 77(3):546-555. PubMed ID: 35767181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine outcome in long-term survivors of childhood brain tumors.
    Shalitin S; Gal M; Goshen Y; Cohen I; Yaniv I; Phillip M
    Horm Res Paediatr; 2011; 76(2):113-22. PubMed ID: 21691048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early endocrine complications in childhood cancer survivors].
    Sánchez González C; Andrades Toledo M; Cárdeno Morales Á; Gutiérrez Carrasco I; Ramírez Villar GL; Pérez Hurtado JM; García García E
    Med Clin (Barc); 2016 Oct; 147(8):329-333. PubMed ID: 27450178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Risk Factors for Endocrine Disorders in Childhood Brain Tumors From a Single Tertiary Center in Malaysia.
    Ng YJ; Jalaludin MY; Foo JC; Qaddoumi I; Rajagopal R
    J Pediatr Hematol Oncol; 2022 May; 44(4):159-166. PubMed ID: 35446802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine Deficiency As a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors.
    Vatner RE; Niemierko A; Misra M; Weyman EA; Goebel CP; Ebb DH; Jones RM; Huang MS; Mahajan A; Grosshans DR; Paulino AC; Stanley T; MacDonald SM; Tarbell NJ; Yock TI
    J Clin Oncol; 2018 Oct; 36(28):2854-2862. PubMed ID: 30118397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary Dysfunction in Patients with Intracranial Germ Cell Tumors Treated with Radiotherapy.
    Xiang B; Zhu X; He M; Wu W; Pang H; Zhang Z; Yang Y; Li Y; Wang Y; Wang Y; Ye H
    Endocr Pract; 2020 Dec; 26(12):1458-1468. PubMed ID: 33471738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting endocrine late effects in childhood cancer survivors from a Japanese hospital.
    Shimazaki S; Kazukawa I; Mori K; Kihara M; Minagawa M
    Endocr J; 2020 Feb; 67(2):131-140. PubMed ID: 31656261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term neuro-endocrine sequelae after treatment for childhood medulloblastoma.
    Heikens J; Michiels EM; Behrendt H; Endert E; Bakker PJ; Fliers E
    Eur J Cancer; 1998 Sep; 34(10):1592-7. PubMed ID: 9893634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term endocrine effects and trends in body mass index changes in patients with childhood-onset brain tumors.
    Seo GH; Choi JH; Kim YM; Koh KN; Im HJ; Ra YS; Yoo HW
    J Neurooncol; 2018 May; 138(1):55-62. PubMed ID: 29352447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.